The nuclear hormone receptor PPARγ counteracts vascular calcification by inhibiting Wnt5a signalling in vascular smooth muscle cells-Reference-Cited by-同舟云学术

The nuclear hormone receptor PPARγ counteracts vascular calcification by inhibiting Wnt5a signalling in vascular smooth muscle cells

Published:2012-01 Issue:1 Volume:3 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Woldt Estelle,Terrand Jérome,Mlih Mohamed,Matz Rachel L.,Bruban Véronique,Coudane Fanny,Foppolo Sophie,El Asmar Zeina,Chollet Maria Eugenia,Ninio Ewa,Bednarczyk Audrey,Thiersé Danièle,Schaeffer Christine,Van Dorsselaer Alain,Boudier Christian,Wahli Walter,Chambon Pierre,Metzger Daniel,Herz Joachim,Boucher Philippe

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/ncomms2087.pdf

Reference46 articles.

1. Wilson, P. W. et al. Abdominal aortic calcific deposits are an important predictor of vascular morbidity and mortality. Circulation 103, 1529–1534 (2001).

2. Sage, A. P., Tintut, Y. & Demer, L. L. Regulatory mechanisms in vascular calcification. Nat. Rev. Cardiol. 7, 528–536 (2010).

3. Walsh, C. R. et al. Abdominal aortic calcific deposits are associated with increased risk for congestive heart failure: the Framingham Heart Study. Am. Heart J. 144, 733–739 (2002).

4. Guzman, R. J. Clinical, cellular, and molecular aspects of arterial calcification. J. Vasc. Surg. 45 (Suppl A), A57–A63 (2007).

5. Karreth, F., Hoebertz, A., Scheuch, H., Eferl, R. & Wagner, E. F. The AP1 transcription factor Fra2 is required for efficient cartilage development. Development 131, 5717–5725 (2004).

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PPARs in atherosclerosis: The spatial and temporal features from mechanism to druggable targets;Journal of Advanced Research;2024-03

2. Vascular calcification and cellular signaling pathways as potential therapeutic targets;Life Sciences;2024-01

3. Serum sclerostin in vascular calcification in CKD: a meta-analysis;Renal Failure;2023-03-07

4. Roles of Vascular Smooth Muscle Cells in Atherosclerotic Calcification;Journal of Lipid and Atherosclerosis;2023

5. Non-canonical WNT signalling in cardiovascular disease: mechanisms and therapeutic implications;Nature Reviews Cardiology;2022-06-13